Mallinckrodt Disgorges $100M, Licenses Competing Drug Under FTC/States Settlement

(January 20, 2017, 12:23 PM EST) -- WASHINGTON, D.C. — British drug maker Mallinckrodt ARD Inc. will disgorge $100 million in profits to settle a complaint by the U.S. Federal Trade Commission and five states that it purchased...
To view the full article, register now.